🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7939635

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7935351

Use of CPG oligodeoxynucleotides to induce angiogenesis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7932074

Multivalent human-bovine rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928096

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related c

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928079

Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7927793

Cell lines and host nucleic acid sequences related to infectious disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919477

Multiple CpG oligodeoxynucleotides and their use to induce an immune response

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919607

Nucleic acids encoding humanized anti-tag 72 CC49 antbodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919301

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914801

Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antib

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915036

Compositions comprising T cell receptors and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914788

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910692

Immunogenic peptides and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910105

Methods for treating and preventing fibrosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902441

Chromosome 3p21.3 genes are tumor suppressors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902348

Janus family kinases and identification of immune modulators

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897575

Treatment and prevention of vascular dementia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897355

Gene expressed in prostate cancer and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892738

Pot1 alternative splicing variants

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892786

Methods for expression and purification of immunotoxins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892569

Methods of altering an immune response induced by CpG oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887818

Neospora caninum vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888116

Uses of notch receptors, notch ligands, and notch modulators in methods related to metabol

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887812

Live attenuated Leishmania vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted